Recursion Pharmaceuticals, Inc. (RXRX) Insider Trading Activity — Form 4 Filings
Recent RXRX insider trading activity from SEC Form 4 filings, including executive and director buys, sells, awards, filing dates, and data limitations.
Direct answer: Recursion Pharmaceuticals, Inc. (RXRX) has more selling than buying in the recent Form 4 activity available here. The data includes 116 parsed transactions from SEC filings.
SEC data retrieved .
Recursion Pharmaceuticals, Inc. insider activity summary
Recent activity includes 0 open-market buys, 80 sells, and other Form 4 transactions. Buy and sell counts summarize the available recent filings; they are not a complete measure of insider conviction.
Recent Form 4 transactions
| Date | Insider | Type | Reported value |
|---|
| Sep 15, 2026 |
Taylor Ben R |
SELL |
$18,400 |
| Sep 8, 2026 |
Khan Najat |
SELL |
$78,822 |
| Sep 1, 2026 |
Borgeson Blake |
SELL |
$100,200 |
| Aug 17, 2026 |
Khan Najat |
SELL |
$254,374 |
| Aug 17, 2026 |
Hallett David |
SELL |
$84,236 |
| Aug 17, 2026 |
Taylor Ben R |
SELL |
$79,057 |
| Aug 4, 2026 |
Borgeson Blake |
SELL |
$97,500 |
| Jul 7, 2026 |
Borgeson Blake |
SELL |
$158,500 |
| Jul 1, 2026 |
Dar Zavain |
AWARD |
Not disclosed |
| Jul 1, 2026 |
Li Dean Y |
AWARD |
Not disclosed |
| Jun 18, 2026 |
Bumpus Namandje |
SELL |
$12,602 |
| Jun 17, 2026 |
Borgeson Blake |
AWARD |
Not disclosed |
Sources and limitations
Source: SEC EDGAR Form 4 filings. Filing data can be delayed, amended, incomplete, or affected by SEC rate limits. Scheduled sales, awards, exercises, and open-market trades have different meanings. This page is informational and is not financial advice.
Frequently asked questions
When was RXRX insider data retrieved?
Sep 20, 2026, 9:30 AM UTC.
Does insider buying guarantee a higher stock price?
No. Insider transactions are one data point and do not predict future returns.
View the full RXRX stock analysis · Search another ticker's Form 4 filings
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.